Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy - Concepedia

Concepedia

Publication | Open Access

Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy

DOI Full Paper Access

158

Citations

43

References

2014

Year

Nicholas Funderburg, Ying Jiang, Sara M. Debanne, Danielle Labbato, Steven Juchnowski, Brian Ferrari, Brian Clagett, Janet Robinson, Michael M. Lederman, Grace A. McComsey

JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

Forty-eight weeks of rosuvastatin treatment reduced significantly several markers of inflammation and lymphocyte and monocyte activation in ART-treated subjects.

References

	Year	Citations
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, New England Journal of Medicine	2008	6.5K
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, Obstetrical & Gynecological Survey Vascular DiseaseElevated C-reactive ProteinUnstable AnginaHyperlipidemiaPharmacotherapy	2009	3.7K
Microbial translocation is a cause of systemic immune activation in chronic HIV infection Jason M. Brenchley, David A. Price, Timothy W. Schacker, Nature Medicine Primary ImmunodeficiencyChronic Hiv InfectionAutoimmune DiseaseViral PersistenceHuman Retrovirus	2006	3.5K
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease Virginia A. Triant, Hang Lee, Colleen Hadigan, The Journal of Clinical Endocrinology & Metabolism	2007	1.6K
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection Lewis H. Kuller, Russell P. Tracy, Waldo Belloso, PLoS Medicine	2008	1.6K
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction New England Journal of Medicine	2007	1.5K
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection Netanya G. Sandler, Handan Wand, Annelys Roque, The Journal of Infectious Diseases	2011	1.1K
Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage Janis V. Giorgi, Lance E. Hultin, Jane A. McKeating, The Journal of Infectious Diseases	1999	1K
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study Nina Friis‐Møller, Rainer Weber, Peter Reiss, AIDS Cardiometabolic RiskDad StudyClinical EpidemiologyPublic HealthDyslipidemia	2003	982
T Cell Activation Is Associated with Lower CD4<sup>+</sup>T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy Peter W. Hunt, Jeffrey N. Martin, Elizabeth Sinclair, The Journal of Infectious Diseases	2003	845

Page 1